Comparative effects of the Dihydropyridine-type calcium-agonists (−)-S-Bay K 8644, (±)-Bay-W 5035 and (±)-Bay-T 5006 on human platelet aggregability
- 31 May 1994
- journal article
- research article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 25 (3) , 447-450
- https://doi.org/10.1016/0306-3623(94)90195-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human plateletsBiochemical and Biophysical Research Communications, 1988
- Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.Circulation Research, 1988
- Kalziumantagonisten und ThrombozytenfunktionHamostaseologie, 1988
- Changes in platelet β‐thromboglobulin, fibrinogen, albumin, 5‐hydroxytryptamine, ATP, and ADP during and after surgery with extracorporeal circulation in manAmerican Journal of Hematology, 1986
- Lack of evidence for voltage dependent calcium channels on plateletsBiochemical and Biophysical Research Communications, 1985
- Effects of verapamil on platelet aggregation, ATP release and thromboxane generationThrombosis Research, 1983
- The effects of nifedipine, a calcium antagonist, on platelet functionAmerican Heart Journal, 1983
- Inhibition of human platelet function by verapamilThrombosis Research, 1982
- Effects by nifedipine (Adalat®) on platelet function in vitro and in vivoThrombosis Research, 1981